Results 281 to 290 of about 103,807 (331)

Machine Learning-Driven radiomics on 18 F-FDG PET for glioma diagnosis: a systematic review and meta-analysis. [PDF]

Cancer Imaging
Shahriari A, Ghazanafar Ahari S, Mousavi A, Sadeghi M, Abbasi M, Hosseinpour M, Mir A, Zohouri Zanganeh D, Gharedaghi H, Ezati S, Sareminia A, Seyedi D, Shokouhfar M, Darzi A, Ghaedamini A, Zamani S, Khosravi F, Asadi Anar M.   +17 more
europepmc   +1 more source

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

CNS Neuroscience &Therapeutics, Volume 31, Issue 12, December 2025.
The limited clinical efficacy of anti‐Aβ antibodies has challenged the Aβ hypothesis, compelling the integration of key mechanisms—including neuroinflammation, mitochondrial dysfunction, oxidative stress, and post‐translational modifications of Aβ—into a revised model of Alzheimer's disease.
Shamseddin Ahmadi, Shiler Khaledi, Kimia Ahmadi, Kambiz Hassanzadeh   +3 more
wiley   +1 more source

Reprogramming the tumour microenvironment: Emerging strategies to overcome immunotherapy resistance

Clinical and Translational Discovery, Volume 5, Issue 6, December 2025.
Reprogramming the tumour microenvironment (TME) overcomes immunotherapy resistance by targeting immunosuppressive cells, abnormal vasculature and metabolic dysregulation. Emerging strategies, including epigenetic modulation, vascular normalisation and cellular therapies, transform the TME into an immune‐active landscape, enhancing T‐cell infiltration ...
Mohammed Elmujtba Adam Essa, Shahd Elbadri, Abdelkareem A. Ahmed, Hamid Noori   +3 more
wiley   +1 more source

Direct Comparison of ⁶⁷Ga-Scintigraphy and Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Cardiac Sarcoidosis. [PDF]

JACC Adv
Kurashima S, Kitai T, Nabeta T, Naruse Y, Taniguchi T, Miyakoshi C, Miyoshi Y, Tanaka H, Morimoto R, Baba Y, Furukawa Y, Matsue Y, Izumi C.   +12 more
europepmc   +1 more source

Mechanisms, impacts and therapeutic strategies of glucose metabolic reprogramming in tumours

Clinical and Translational Discovery, Volume 5, Issue 6, December 2025.
Tumour metabolic reprogramming initiates a vicious cycle of immunosuppression and therapy resistance. This synergy disarms immunity and fortifies tumour cells, ultimately driving clonal evolution of resistant disease. Abstract Background Glucose metabolic reprogramming is a hallmark of cancer, best exemplified by the Warburg effect.
Li Ma, Ming‐yang Wu, Cui‐cui Tian, Hao‐ze Shi, Dan Song   +4 more
wiley   +1 more source

Diagnostic Challenges in Antiphospholipid Antibody-Associated Chorea: A Case Report. [PDF]

Case Rep Neurol Med
Robin A, Vitte T, Minotti L, Kahane P.
europepmc   +1 more source

Inflammation and genetics in myo‐pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases

ESC Heart Failure, Volume 12, Issue 6, Page 3987-3999, December 2025.
Proposed management of myo‐pericardial diseases. A systematic interdisciplinary approach to myo‐pericardial disease is essential to reach a correct diagnosis, starting from multiparametric characterization including EKG, echocardiography with GLS, laboratory exams and CMR or, in case of electric or haemodynamic instability, EMB.
Marco Merlo, Giulia Bassetto, Antonio Cannatà, Alberto Aimo, Camillo Autore, Barbara Bauce, Elena Biagini, Francesco Cappelli, Silvia Castelletti, Flavio D'Ascenzi, Cesare de Gregorio, Giuseppe Limongelli, Francesca Marzo, Beatrice Musumeci, Giacomo Tini, Roberto Pedrinelli, Pasquale Perrone Filardi, Gianfranco Sinagra, Massimo Imazio   +18 more
wiley   +1 more source

A Deadly Duet: Fanconi Anemia (FA) With Head and Neck Cancer. [PDF]

Cureus
D C, Js L, John C, K SS.
europepmc   +1 more source

A pilot study treatment of malignant tumors using low-dose ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG).

, 2020
Doru Paul, Cristina Maria Ghiuzeli, Josephine N. Rini, Christopher J. Palestro, Edward K. Fung, Maged P. Ghali, Eran Ben‐Levi, Andrew Prideaux, Shankar Vallabhajosula, E Popa   +9 more
openalex   +1 more source

Radiofrequency thermocoagulation for the treatment of refractory focal status epilepticus

Epileptic Disorders, Volume 27, Issue 6, Page 1292-1297, December 2025.
Abstract This case study reports the first documented use of stereoelectroencephalography (SEEG)‐guided radiofrequency thermocoagulation (RFTC) to treat refractory status epilepticus (RSE). A 33‐year‐old woman with drug‐resistant epilepsy and recurrent RSE underwent SEEG to define her epileptogenic zone.
Odile Feys, Julia Makhalova, Thomas Manners, José‐David Herrera‐García, Romain Carron, Fabrice Bartolomei   +5 more
wiley   +1 more source